Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter STK26/MST4 Antikörper

Der Kaninchen Monoklonal anti-STK26/MST4 Antikörper (Klon 29S79) (ABIN7882241) detektiert spezifisch STK26/MST4 in WB und IHC. Dieser Antikörper reagiert spezifisch mit Proben aus Human, Maus und Ratte.
Produktnummer ABIN7882241
644,88 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μL
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Rekombinanter STK26/MST4 Antikörper (ABIN7882241)

Target

Alle STK26/MST4 (MST4) Antikörper anzeigen
STK26/MST4 (MST4) (Serine/threonine-Protein Kinase MST4 (MST4))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 75
  • 34
  • 22
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 66
  • 7
  • 2
Kaninchen

Klonalität

  • 57
  • 18
Monoklonal

Konjugat

  • 40
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser STK26/MST4 Antikörper ist unkonjugiert

Applikation

  • 65
  • 24
  • 24
  • 13
  • 13
  • 11
  • 7
  • 3
  • 3
  • 3
  • 3
Western Blotting (WB), Immunohistochemistry (IHC)

Klon

29S79
  • Verwendungszweck

    STK26 Antibody / MST4 / MASK

    Aufreinigung

    Affinity-chromatography

    Immunogen

    A synthesized peptide derived from human MST4 was used as the immunogen for the STK26 antibody.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal dilution of the STK26 antibody should be determined by the researcher.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store the STK26 antibody at -20oC.
  • Target

    STK26/MST4 (MST4) (Serine/threonine-Protein Kinase MST4 (MST4))

    Andere Bezeichnung

    STK26

    Hintergrund

    STK26 antibody recognizes serine threonine kinase 26, a signaling kinase that participates in cell proliferation, apoptosis, and polarity regulation. STK26, sometimes referred to as MST4 or MASK associated protein, is a member of the germinal center kinase family. It is encoded by the STK26 gene and functions downstream of multiple signaling pathways including the Hippo pathway. Through phosphorylation of substrates involved in cytoskeletal dynamics and transcriptional regulation, STK26 contributes to cellular architecture and growth control.

    STK26 antibody is commonly applied in studies of cancer, epithelial polarity, and kinase signaling. In epithelial cells, STK26 regulates apical basal polarity and tissue organization. In cancer, STK26 expression has been associated with tumor progression, migration, and invasion. By detecting STK26 expression, researchers can examine how dysregulation of this kinase influences malignancy and whether it serves as a useful biomarker.

    The antibody is suitable for western blotting, immunohistochemistry, and immunofluorescence. In western blot assays, STK26 antibody detects protein bands corresponding to the expected size, confirming expression across different samples. Immunohistochemistry highlights tissue localization of the kinase, while immunofluorescence provides single cell resolution of its cytoplasmic and membrane associated distribution. These applications make STK26 antibody a versatile tool for exploring kinase activity in diverse biological contexts.

    Research has shown that STK26 interacts with adaptor proteins such as MASK and kinases like MST4, forming scaffolding complexes that integrate signaling networks. These complexes influence cell polarity, cytoskeletal organization, and transcription factor regulation. STK26 is also implicated in Hippo signaling, a pathway that governs tissue size and cellular proliferation by balancing growth and apoptosis. By using STK26 antibody, scientists can evaluate how this kinase contributes to developmental biology and disease progression.

    In oncology, altered STK26 expression has been reported in certain cancers, where its activity may support invasion and metastasis. Experimental models suggest that modulation of STK26 influences tumor cell migration, making it a potential therapeutic target. Beyond cancer, STK26 plays roles in tissue morphogenesis, neuronal polarity, and immune regulation. Antibodies against STK26 therefore support a broad range of research into cellular organization and signaling.

    STK26 antibody provided by NSJ Bioreagents offers researchers a specific and dependable reagent for studying kinase mediated signaling, polarity establishment, and cancer biology. Its reliability across multiple applications makes it a valuable resource for laboratories investigating cellular signaling networks.

    UniProt

    Q9P289
Sie sind hier:
Chat with us!